We are live on ! Find out more
ZYME icon

Zymeworks

173 hedge funds and large institutions have $973M invested in Zymeworks in 2024 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 47 increasing their positions, 61 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

106% more call options, than puts

Call options by funds: $547K | Put options by funds: $266K

60% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 20

6% more funds holding

Funds holding: 163 → 173 (+10)

2.81% more ownership

Funds ownership: 93.7% → 96.52% (+2.8%)

2% more capital inflows, than outflows

Capital inflows: $77.3M | Capital outflows: $75.9M

23% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 61

Holders
173
Holders Change
+10
Holders Change %
+6.13%
% of All Funds
2.27%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.07%
New
32
Increased
47
Reduced
61
Closed
20
Calls
$547​K
Puts
$266​K
Net Calls
+$281​K
Net Calls Change
+$7.41​M

ZYME Hedge Fund Activity: Q4 2024 in Review

173 of the 7,628 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q4 2024, worth a combined $973M — up 17% from $835M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new ZYME positions and 20 closed out — a net gain of 12 holders — while 47 added to existing stakes and 61 trimmed.

The largest buyer was EcoR1 Capital, adding an estimated $22.2M. The largest seller was Morgan Stanley, cutting an estimated $12.7M.

  • 173 institutional investors held Zymeworks (ZYME) as of Q4 2024, up from 163 in Q3 2024.
  • Funds reported $973M of Zymeworks stock for Q4 2024, up 17% quarter-over-quarter.
  • 32 funds opened new Zymeworks positions in Q4 2024 and 20 closed out, a net change of +12 holders.
  • The largest Zymeworks buyer in Q4 2024 was EcoR1 Capital, an estimated $22.2M added.
  • The largest Zymeworks seller in Q4 2024 was Morgan Stanley, an estimated $12.7M sold.

Based on aggregated 13F filings for Q4 2024.